Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss (Q34013478)

30 July 2017

Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss (English)

1 reference

30 July 2017

1 reference

Alexander Tschoner

1

1 reference

30 July 2017

Wolfgang Sturm

2

1 reference

30 July 2017

Julia Engl

3

1 reference

30 July 2017

Susanne Kaser

4

1 reference

30 July 2017

Markus Laimer

5

1 reference

30 July 2017

Elisabeth Laimer

6

1 reference

30 July 2017

Helmut Weiss

7

1 reference

30 July 2017

Josef R Patsch

8

1 reference

30 July 2017

Christoph F Ebenbichler

9

1 reference

30 July 2017

14 August 2008

1 reference

30 July 2017

1 reference

30 July 2017

16

1 reference

30 July 2017

2439-2444

1 reference

30 July 2017

11

1 reference

Abdominal obesity and metabolic syndrome

30 July 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Adipocytes as regulators of energy balance and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Mechanisms linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Why visceral fat is bad: mechanisms of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Leptin and ghrelin expression in adipose tissues and serum levels in gastric banding patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Comparison of leptin gene expression in different adipose tissues in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Retinol-binding protein 4 in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Influence of age on the association of retinol-binding protein 4 with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Metabolic and body composition factors in subgroups of obesity: what do we know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Obesity as a medical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Results and complications after adjustable gastric banding in a series of 250 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Ultrasound measurement of visceral and subcutaneous fat in morbidly obese patients before and after laparoscopic adjustable gastric banding: comparison with computerized tomography and with anthropometric measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Cholesteryl Ester Transfer Protein in Metabolic Syndrome*

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

Banting lecture 1988. Role of insulin resistance in human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

7 January 2021

Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

7 January 2021

Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

7 January 2021

Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.391

7 January 2021

Identifiers

DOI

10.1038/OBY.2008.391

1 reference

30 July 2017

1 reference